ACADIA Pharmaceuticals Inc. vs Cardinal Health Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Cardinal Health Inc trades at $240.13 (market cap $55.88B). The key difference: Cardinal Health Inc is far larger — about 11× ACADIA Pharmaceuticals Inc.'s market cap, and Cardinal Health Inc pays a 0.86% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | CAH | |
|---|---|---|
Market Cap | $5.07B | $55.88B |
Sector | Health | Health |
52-Week High | $29.41 | $240.26 |
52-Week Low | $20.06 | $146.04 |
Enterprise Value | $4.19B | $59.91B |
Dividend Yield | — | 0.86% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →